Literature DB >> 14753451

Antioxidant properties of the vasoactive endocannabinoid, 2-arachidonoyl glycerol (2-AG).

R M McCarron1, E Shohami, D Panikashvili, Y Chen, S Golech, A Strasser, R Mechoulam, M Spatz.   

Abstract

Reactive oxygen species (ROS) were shown to play a role in altering blood-brain barrier (BBB) permeability and formation of brain edema induced by trauma and/or ischemia. 2-arachidonoyl glycerol (2-AG), a novel, potent vasodilatory and cytoprotective endocannabinoid has been implicated to act as an antioxidative agent. This study examines: 1) the possible 2-AG modulation of BBB injury and edema formation induced by closed head injury (CHI); and 2) comparable effects between 2-AG and 4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl (TPL), a known antioxidant nitroxide on endothelial Ca2+ and cytoskeletal responses to H2O2 (ROS). 2-AG treatment reduced the CHI-induced increase in BBB permeability and brain edema. The endothelial H2O2-stimulated Ca2+ mobilization and cytoskeleton (vimentin) rearrangement was modified by either 2-AG or TPL. These findings provide evidence of 2-AG antioxidant activity and are consistent with the involvement of ROS in the pathomechanism of CHI-induced BBB injury and brain edema.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14753451     DOI: 10.1007/978-3-7091-0651-8_59

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  3 in total

1.  Reversal of postischemic hypoperfusion by tempol: endothelial signal transduction mechanism.

Authors:  Tomoaki Okada; Kohsuke Teranishi; Ye Chen; Toshiki Tomori; Alois Strasser; Frederick A Lenz; Richard M McCarron; Maria Spatz
Journal:  Neurochem Res       Date:  2011-12-03       Impact factor: 3.996

Review 2.  Endocannabinoids and traumatic brain injury.

Authors:  R Mechoulam; E Shohami
Journal:  Mol Neurobiol       Date:  2007-09-18       Impact factor: 5.590

3.  The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action.

Authors:  D M Kerr; B Harhen; B N Okine; L J Egan; D P Finn; M Roche
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.